A Fruitful Display: Sansure Showcases Comprehensive IVD Solutions Portfolio at AACC 2022
2022-07-29 yang, rongchang

A Fruitful Display: Sansure Showcases Comprehensive IVD Solutions Portfolio at AACC 2022


Sansure Biotech Jul 29,2022

The 2022 AACC Annual Scientific Meeting and Clinical Lab Expo was held from July 24th to 28th. The exhibition showcased cutting-edge technologies that would shape the future of laboratory medicine. From July 26th to July 28th, Sansure attended the AACC Expo as an international enterprise that leads IVD industry in the world.

The AACC Annual Scientific Meeting and Clinical Laboratory Expo allows laboratory medicine professionals to network with global leaders in the breakthrough science of laboratory medicine. AACC exhibits products in more than 200 categories each year. In addition, there are more than 250 educational sessions in the form of lectures, plenary sessions, scientific conferences, and roundtables. AACC’s spirit of information sharing, educational dissemination, and technological breakthroughs aligns perfectly with Sansure’s values of innovation, research, and sharing.

As a supplier of in vitro diagnostic products, Sansure is committed to providing diagnostic solutions that contribute to people’s health. At AACC 2022, we showcased Sansure comprehensive diagnostic solutions, including a wide range of diagnostic tests for SARS-CoV-2, respiratory tract infections, viral hepatitis, sexually transmitted infections, transfusion transmitted infections, as well as our nucleic acid extraction solutions (Natch 48, Natch 16S, Natch CS2), Real-time PCR solutions (SLAN-96P, MA-1630Q), and POCT solutions (iPonatic S-Q31B, iPonatic S-Q36A), with full details and live demonstrations.

Sansure’s POCT solution is the most popular in this exhibition, and iPonatic S-Q36A is the star product. iPonatic S-Q36A is a molecular POC device that integrates nucleic acid extraction, amplification detection and data analysis, featuring sample-in & result-out. Moreover, this latest iPonatic S-Q36A has already obtained CE mark under IVDR, it will be installed in more scenarios and play an essential role in the global healthcare system.

Additionally, a lecture presented by Vivian Chen attracted lots of audients at the exhibition, which focused on the future trend of molecular diagnosis in the world and introduction of Sansure’s CE list A products (HBV, HCV, HIV and NAT Blood Screening assay).

Although AACC exhibition has ended, Sansure will continue to provide highly accessible products and solutions to the world. We would like to express our sincere gratitude to all visitors in the three-day AACC exhibition, you are also welcome to explore Sansure’s various novel technologies on our website and social media. Let’s see each other in the next global exhibition.

Sansure, innovating diagnostics for all!

×
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.
SUBMIT

Thank you!

We shall contact you soon!